Christopher C Nessel
Overview
Explore the profile of Christopher C Nessel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
5300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Vemulapalli S, Hellkamp A, Jones W, Piccini J, Mahaffey K, Becker R, et al.
Am Heart J
. 2016 Aug;
178:74-84.
PMID: 27502854
Background: We conducted a retrospective analysis examining the association between systolic blood pressure (SBP) or hypertension bracket and stroke risk in patients with atrial fibrillation (AF). Methods: The study included...
22.
Piccini J, Hellkamp A, Washam J, Becker R, Breithardt G, Berkowitz S, et al.
Circulation
. 2016 Jul;
134(2):e7-8.
PMID: 27400902
No abstract available.
23.
Fordyce C, Hellkamp A, Lokhnygina Y, Lindner S, Piccini J, Becker R, et al.
Circulation
. 2016 Jul;
134(1):37-47.
PMID: 27358435
Background: Despite rapid clinical adoption of novel anticoagulants, it is unknown whether outcomes differ among patients with worsening renal function (WRF) taking these new drugs compared with warfarin. We aimed...
24.
DeVore A, Hellkamp A, Becker R, Berkowitz S, Breithardt G, Hacke W, et al.
Europace
. 2016 May;
18(8):1135-42.
PMID: 27174904
Aims: The high costs associated with treatment for atrial fibrillation (AF) are primarily due to hospital care, but there are limited data to understand the reasons for and predictors of...
25.
Pokorney S, Piccini J, Stevens S, Patel M, Pieper K, Halperin J, et al.
J Am Heart Assoc
. 2016 Mar;
5(3):e002197.
PMID: 26955859
Background: Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. Methods And Results: In the Rivaroxaban Once...
26.
Breithardt G, Baumgartner H, Berkowitz S, Hellkamp A, Piccini J, Lokhnygina Y, et al.
Heart
. 2016 Feb;
102(13):1036-43.
PMID: 26888572
Objective: To compare the characteristics and outcomes of patients with atrial fibrillation (AF) and aortic stenosis (AS) with patients with AF with mitral regurgitation (MR) or aortic regurgitation (AR) and...
27.
Piccini J, Hellkamp A, Washam J, Becker R, Breithardt G, Berkowitz S, et al.
Circulation
. 2015 Dec;
133(4):352-60.
PMID: 26673560
Background: Patients with atrial fibrillation (AF) often take multiple medications. Methods And Results: We examined characteristics and compared adjusted outcomes between rivaroxaban and warfarin according to number of concomitant baseline...
28.
Sherwood M, Nessel C, Hellkamp A, Mahaffey K, Piccini J, Suh E, et al.
J Am Coll Cardiol
. 2015 Nov;
66(21):2271-2281.
PMID: 26610874
Background: Gastrointestinal (GI) bleeding is a common complication of oral anticoagulation. Objectives: This study evaluated GI bleeding in patients who received at least 1 dose of the study drug in...
29.
Bansilal S, Bloomgarden Z, Halperin J, Hellkamp A, Lokhnygina Y, Patel M, et al.
Am Heart J
. 2015 Sep;
170(4):675-682.e8.
PMID: 26386791
Background: The prevalence of both atrial fibrillation (AF) and diabetes mellitus (DM) are rising, and these conditions often occur together. Also, DM is an independent risk factor for stroke in...
30.
Washam J, Stevens S, Lokhnygina Y, Halperin J, Breithardt G, Singer D, et al.
Lancet
. 2015 Mar;
385(9985):2363-70.
PMID: 25749644
Background: Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial data. We studied the use and outcomes...